Search

Yutaka B Niihara

from Rolling Hills Estates, CA
Age ~65
Get Report
Also known as:
Yutaka Nihara, Yutaka Shimabukro
Phone and address:
24 Covered Wagon Ln, Palos Verdes Estates, CA 90274
(310) 544-4681
Related to:
Albert A Niihara, 39Hope Niihara
Connected to:
Michiru Niimi, 53Noriaki K Niimura, 60Rebecca B Niitsuma, 72Guy T Niizawa, 66Jacques A Nijankin, 53Nadia M Nijaradze, 61Marielle M Nijdam, 75Ahmad F Nijem, 63Ramzi R Nijem, 33Neha Nijhara, 52

Yutaka Niihara Phones & Addresses

  • 24 Covered Wagon Ln, Palos Verdes Peninsula, CA 90274 (310) 544-4681
  • 27916 Alvarez Dr, Rancho Palos Verdes, CA 90275
  • Rolling Hills Estates, CA
  • Torrance, CA
  • Los Angeles, CA
  • Riverside, CA
  • Minnetonka, MN
  • Rocklin, CA

Work

Company: UNIVERSITY OF CALIFORNIA LOS ANGELES MEDICAL CENTER Address: 21840 Normandie Ave Suite 700, Torrance, CA 90502

Education

School / High School: Loma Linda University 1986

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Hematology, 1992

Specialities

Hematology • Medical Oncology • Oncology

Professional Records

Medicine Doctors

Yutaka Niihara Photo 1

Dr. Yutaka Niihara - MD (Doctor of Medicine)

View page
Specialties:
Hematology
Medical Oncology
Oncology
Certifications:
Hematology, 1992
Internal Medicine, 1990
Medical Oncology, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1000 W Carson St Suite 480, Torrance, CA 90502

UNIVERSITY OF CALIFORNIA LOS ANGELES MEDICAL CENTER
21840 Normandie Ave Suite 700, Torrance, CA 90502

HARBOR UCLA MEDICAL CENTER
1000 W Carson St, Torrance, CA 90502

Torrance
1000 W Carson St Suite 405, Torrance, CA 90502

Harbor - UCLA Medical Center
1000 West Carson Street, Torrance, CA 90502
Education:
Medical School
Loma Linda University
Graduated: 1986
Medical School
Kettering Med Ctr
Graduated: 1986
Medical School
Harbor-Ucla
Graduated: 1986
Yutaka Niihara Photo 2

Yutaka Niihara, Torrance CA

View page
Specialties:
Internal Medicine
Hematology & Oncology
Hematology
Medical Oncology
Work:
Los Angeles County - Harbor - UCLA Medical Center
1000 W Carson St, Torrance, CA 90502
Los Angeles County - Harbor - UCLA Medical Center
1124 W Carson St, Torrance, CA 90502
Education:
Loma Linda University (1986)
Yutaka Niihara Photo 3

Yutaka Niihara, Torrance CA

View page
Specialties:
Internist
Address:
1124 W Carson St, Torrance, CA 90502
1000 W Carson St, Torrance, CA 90502
21840 Normandie Ave, Torrance, CA 90502
Education:
Loma Linda University, School of Medicine - Doctor of Medicine
Los Angeles County Harbor-UCLA Medical Center - Fellowship - Hematology and Oncology (Internal Medicine)
Kettering Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)

Resumes

Resumes

Yutaka Niihara Photo 4

Chairman

View page
Location:
Torrance, CA
Industry:
Pharmaceuticals
Work:
Emmaus Life Sciences, Inc
Chairman
Ucla
Clinical Professor of Medicine
Ucla Jul 1999 - Jun 2005
Associate Clinical Professor of Medicine
Emmaus Life Sciences, Inc Jul 1999 - Jun 2005
Chief Executive Officer
Ucla Jul 1992 - Jun 1999
Assistant Clinical Professor of Medicine
Education:
Harvard T.h. Chan School of Public Health 2002 - 2006
Master of Public Health, Masters Harvard T.h. Chan School of Public Health 2006 - 2006
Master of Public Health, Masters Loma Linda University 1982 - 1986
Doctor of Medicine, Doctorates, Medicine Loma Linda University 1978 - 1982
Bachelors, Bachelor of Arts
Skills:
Clinical Research
Medicine
Strategic Planning
Pharmaceutical Industry
Biotechnology
Life Sciences
Start Ups
Strategy
Research
Healthcare
Marketing Strategy
Clinical Trials
Management
Business Strategy
Cell
Oncology
Public Speaking
New Business Development
Business Planning
Business Development
Project Management
Hospitals
Product Development
Change Management
Cross Functional Team Leadership
Cell Biology
Hematology
Organization Skills
Sales Management
Internal Medicine
Yutaka Niihara Photo 5

Chief Executive Officer

View page
Location:
24 Covered Wagon Ln, Rolling Hills Estates, CA 90274
Industry:
Pharmaceuticals
Work:
Emmaus Life Scineces
Chief Executive Officer

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yutaka Niihara
President, Owner
HOPE INTERNATIONAL HOSPICE, INC
Individual/Family Services
20705 S Western Ave STE 112, Torrance, CA 90501
(310) 782-7070, (310) 782-7245
Yutaka Niihara
President, CEO
EMMAUS MEDICAL, INC
Mfg Surface Active Agents · Druggists' Goods Merchant Whols
21250 Hawthorne Blvd STE 800, Torrance, CA 90503
3870 Del Amo Blvd, Torrance, CA 90503
20725 S Western Ave, Torrance, CA 90501
(310) 214-0065, (310) 214-0075
Yutaka Niihara
Principal
Soomi Niihara
Business Services at Non-Commercial Site
24 Covered Wagon Ln, Palos Verdes Estates, CA 90274
Yutaka Niihara
Medical Doctor
Medical Oncology Department
Medical Doctor's Office
1000 W Carson St, Torrance, CA 90502
Yutaka Niihara
President, Chief Executive Officer
EMMAUS LIFE SCIENCES, INC
Health/Allied Services · Mfg Pharmaceutical Preparations
21250 Hawthorne Blvd STE 800, Torrance, CA 90503
10100 Santa Monica Blvd, Los Angeles, CA 90067
20725 S Western Ave, Torrance, CA 90501
20725 S Wstn Ave, Torrance, CA 90501
(310) 214-0065
Yutaka Niihara
Yutaka Niihara MD
Internist
1000 W Carson St, Torrance, CA 90502
(310) 222-2345
Yutaka Niihara
President
NEWFIELD NUTRITION CORPORATION
Mfg Dietary Supplements
Newfield Nutrition Corporation, Torrance, CA 90501
3870 Del Amo Blvd, Torrance, CA 90503
20725 S Western Ave, Torrance, CA 90501
(310) 214-1723
Yutaka Niihara
Emmaus Medical, LLC
Pharmacrutical
27916 Alvarez Dr, Palos Verdes Estates, CA 90275

Publications

Us Patents

Methods And Compositions For The Treatment Of Diverticulosis

View page
US Patent:
20130178531, Jul 11, 2013
Filed:
Dec 14, 2012
Appl. No.:
13/694592
Inventors:
Emmaus Medical, Inc. - Torrance CA, US
Yutaka Niihara - Rolling Hills Estates CA, US
Assignee:
Emmaus Medical, Inc. - Torrance CA
International Classification:
A61K 31/198
US Classification:
514563
Abstract:
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.

Methods And Compositions For The Treatment Of Diverticulosis

View page
US Patent:
20220202758, Jun 30, 2022
Filed:
Mar 9, 2022
Appl. No.:
17/803158
Inventors:
- Torrance CA, US
Yutaka Niihara - Rolling Hills Estates CA, US
Assignee:
Emmaus Medical, Inc. - Torrance CA
International Classification:
A61K 31/198
A61K 31/717
A61K 31/721
A61K 36/68
A23L 33/24
A23L 33/10
A23L 33/00
A23L 33/175
A23L 33/105
Abstract:
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.

Methods And Compositions For The Treatment Of Sickle Cell Diseases And Thalassemia

View page
US Patent:
20210015775, Jan 21, 2021
Filed:
Jul 17, 2019
Appl. No.:
16/501994
Inventors:
- Torrance CA, US
Yutaka Niihara - Rolling Hills Estates CA, US
International Classification:
A61K 31/198
A61K 47/36
A61P 7/06
Abstract:
The present invention is generally directed to methods and compositions for the treatment of sickle cell diseases and thalassemia. It is more particularly directed to compositions containing L-glutamine, an L-glutamine salt or an L-glutamine derivative and at least one other active ingredient and methods using such compositions. In one aspect, the present invention is directed to a composition for treating sickle cell disease or β-thalassemia. The composition comprises: at least one gram of L-glutamine, an L-glutamine salt or an L-glutamine derivative; and, at least one gram of one type of fiber.

Methods And Compositions For The Treatment Of Sickle Cell Diseases And Thalassemia

View page
US Patent:
20210015778, Jan 21, 2021
Filed:
Apr 30, 2020
Appl. No.:
16/873542
Inventors:
- Torrance CA, US
Yutaka Niihara - Rolling Hills Estates CA, US
Assignee:
Emmaus Medical, Inc. - Torrance CA
International Classification:
A61K 31/198
A61K 47/36
A61P 7/06
Abstract:
The present invention is generally directed to methods and compositions for the treatment of sickle cell diseases and thalassemia. It is more particularly directed to compositions containing L-glutamine, an L-glutamine salt or an L-glutamine derivative and at least one other active ingredient and methods using such compositions. In one aspect, the present invention is directed to a composition for treating sickle cell disease or β-thalassemia. The composition comprises: at least one gram of L-glutamine, an L-glutamine salt or an L-glutamine derivative; and, at least one gram of one type of fiber.

Methods And Compositions For The Treatment Of Diverticulosis

View page
US Patent:
20190201361, Jul 4, 2019
Filed:
Feb 11, 2019
Appl. No.:
16/501039
Inventors:
- Torrance CA, US
Yutaka Niihara - Rolling Hills Estates CA, US
International Classification:
A61K 31/198
A23L 33/24
A23L 33/00
A23L 33/175
A23L 33/105
A61K 31/717
A23L 33/10
A61K 36/68
A61K 31/721
Abstract:
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.

Methods And Compositions For The Treatment Of Diverticulosis

View page
US Patent:
20170157080, Jun 8, 2017
Filed:
Feb 10, 2017
Appl. No.:
15/530630
Inventors:
- Torrance CA, US
Yutaka Niihara - Rolling Hills Estates CA, US
International Classification:
A61K 31/198
A61K 31/721
A61K 36/68
A23L 33/10
A23L 33/24
A23L 33/105
A23L 33/175
A61K 31/717
A23L 33/00
Abstract:
The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
Control profile
Yutaka B Niihara from Rolling Hills Estates, CA, age ~65 Get Report